Medicare Enrolled
Dr. Haidy Behman, MD
Neurology · Carteret, NJ
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Behman from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Behman?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Behman
Dr. Haidy Behman is a neurology specialist in Carteret, NJ, with 20 years of NPI registration. Based on federal Medicare data, Dr. Behman performed 2,221 Medicare services across 1,164 unique beneficiaries.
Between the years covered by Open Payments, Dr. Behman received a total of $7,700 from 57 pharmaceutical and/or device companies across 387 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in neurology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Behman is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ Top 17% volume in NJ
$7,700 industry payments
Medicare Practice Summary
Medicare Utilization ↗2,221
Medicare services
Top 17% in NJ for neurology
1,164
Unique beneficiaries
$95
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~111 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
853 | $68 | $175 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
368 | $103 | $200 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
250 | $147 | $400 |
| EEG, extended monitoring A test that records electrical activity in the brain while the patient is both awake and asleep. |
243 | $48 | $250 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
192 | $102 | $225 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
105 | $154 | $250 |
| New patient office visit, complex (60-74 min) | 56 | $176 | $315 |
| EEG brain wave monitoring, 41-60 minutes This procedure involves monitoring and recording electrical activity in the brain using electrodes placed on the scalp for a duration of 41 to 60 minutes. |
51 | $296 | $969 |
| MRI scan of brain, without contrast A magnetic resonance imaging test of the brain that does not use contrast dye. This procedure creates detailed images of the brain's structure using magnetic fields and radio waves. |
45 | $61 | $250 |
| CT scan of head/brain, without contrast A CT scan uses X-rays to create detailed images of the head or brain without the use of contrast dye. |
16 | $34 | $150 |
| MRI of brain with and without contrast An MRI scan of the brain using contrast dye both before and after administration to provide detailed images of brain structures. |
15 | $94 | $250 |
| MRI of upper spine without contrast An MRI scan of the upper spinal canal that does not use contrast dye. This imaging test uses magnetic fields and radio waves to create detailed pictures of the spine. |
15 | $59 | $250 |
| MRI of lower spine, without contrast A magnetic resonance imaging scan of the lower spinal canal that does not use contrast dye to create detailed images of the spine. |
12 | $58 | $250 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$7,700
Total received (2018-2024)
Avg $1,100/year across 7 years
Top 28% in NJ for neurology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
57
Companies
387
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$7,483 (97.2%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$217 (2.8%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,376
2023
$1,441
2022
$1,043
2021
$1,349
2020
$769
2019
$1,039
2018
$683
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Lilly USA, LLC
$394
ABBVIE INC.
$338
Corcept Therapeutics
$111
Neurocrine Biosciences, Inc.
$103
Abbott Laboratories
$93
PFIZER INC.
$85
Insulet Corporation
$47
Lundbeck LLC
$37
RECORDATI_RARE_DISEASES_INC.
$32
Novo Nordisk Inc
$31
Boehringer Ingelheim Pharmaceuticals, Inc.
$30
Dexcom, Inc.
$17
Celgene Corporation
$17
Averitas Pharma Inc.
$16
ARGENX US, INC.
$14
Embecta Corp.
$14
Top 3 companies account for 61.2% of 2024 payments
All-time payments by company (2018-2024) ›
Lilly USA, LLC
$1,431
ABBVIE INC.
$640
AbbVie Inc.
$475
Teva Pharmaceuticals USA, Inc.
$383
Corcept Therapeutics
$380
Biohaven Pharmaceuticals, Inc.
$331
Novo Nordisk Inc
$313
Abbott Laboratories
$252
Dexcom, Inc.
$250
Lundbeck LLC
$245
Kyowa Kirin, Inc.
$237
Alexion Pharmaceuticals, Inc.
$201
Eisai Inc.
$194
Amgen Inc.
$188
PFIZER INC.
$174
UCB, Inc.
$149
DEXCOM, INC.
$113
SK Life Science, Inc.
$112
BOSTON SCIENTIFIC CORPORATION
$106
Merck Sharp & Dohme Corporation
$104
Amneal Pharmaceuticals LLC
$104
Neurocrine Biosciences, Inc.
$103
Insulet Corporation
$89
Zimmer Biomet Holdings, Inc.
$86
SANOFI-AVENTIS U.S. LLC
$76
Medtronic MiniMed, Inc.
$66
Janssen Pharmaceuticals, Inc
$63
Boehringer Ingelheim Pharmaceuticals, Inc.
$56
Allergan, Inc.
$50
Supernus Pharmaceuticals, Inc.
$50
Greenwich Biosciences, Inc.
$48
Embecta Corp.
$45
Scilex Pharmaceuticals Inc.
$43
Catalyst Pharmaceuticals, Inc.
$42
LifeScan, Inc.
$42
ARGENX US, INC.
$34
Valeritas, Inc.
$34
Biogen, Inc.
$33
RECORDATI_RARE_DISEASES_INC.
$32
Biohaven Pharmaceutical Holding Company Ltd.
$30
AQUESTIVE THERAPEUTICS, INC.
$29
Mannkind Corporation
$25
CATALYST PHARMACEUTICALS, INC.
$24
Medtronic, Inc.
$23
Ultragenyx Pharmaceutical Inc.
$19
Novartis Pharmaceuticals Corporation
$18
Xeris Pharmaceuticals, Inc.
$17
Celgene Corporation
$17
Daiichi Sankyo Inc.
$16
Averitas Pharma Inc.
$16
Vertical Pharmaceuticals, LLC
$15
MannKind Corporation
$14
Avion Pharmaceuticals
$13
Takeda Pharmaceuticals U.S.A., Inc.
$13
Alfasigma USA, Inc.
$13
E.R. Squibb & Sons, L.L.C.
$13
EISAI INC.
$12
Top 3 companies account for 33.1% of all-time payments
Associated products mentioned in payments ›
AFREZZA · AIMOVIG · AJOVY · AMYVID · AUSTEDO · Aimovig · BAQSIMI · BD Nano 2nd Gen Pen Needle · Briviact · CRYSVITA · Comprehensive · Crysvita · DEXCOM G6 TRANSMITTER · Dexcom G6 Transmitter · Dhivy · ELIQUIS · EMGALITY · Epidiolex · FIRDAPSE · FREESTYLE LIBRE · FreeStyle Libre · Fycompa · GVOKE HYPOPEN · HUMULIN · INGREZZA · INJECTAFER · INVOKANA · InPen · JANUVIA · JARDIANCE · KISUNLA · Korlym · LYRICA · Leqembi · MOUNJARO · Minimed 670G System · NOURIANZ · NURTEC ODT · Neupro · OT Verio Reflect "One Touch Meter and Strips" · OXTELLAR XR · Omnipod · OneTouch · Ozempic · PAXLOVID · Prolia · QULIPTA · QUTENZA · RELEXXII · RYTARY · Rybelsus · SIGNIFOR LAR · SOLIQUA · SOLIQUA 100/33 · SOLIRIS · SPINRAZA · STEGLATRO · STEGLUJAN · SYMPAZAN · SYNTHROID · Soliris · Strensiq · TOUJEO · TROKENDI XR · TRULICITY · TYSABRI · Tresiba · Trintellix · UBRELVY · V-GO · VERCISE · VYEPTI · VYVGART · VYVGART HYTRULO · Victoza · Vimpat · XCOPRI · ZEPOSIA · ZTLido
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (97%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Neurologists within 10 mi
1,057
Per 100K population
122.7
County median income
$109,028
Nearest hospital
ROBERT WOOD JOHNSON UNIVERSITY HOSPITAL AT RAHWAY
3.2 mi
3.2 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Behman is a clinical cardiology specialist, with above-average Medicare volume (top 17% in NJ), with low-engagement industry engagement, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Behman experienced with hospital follow-up visit, moderate complexity?
Based on Medicare claims data, Dr. Behman performed 853 hospital follow-up visit, moderate complexity services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Behman receive payments from pharmaceutical companies?
Yes. Dr. Behman received a total of $7,700 from 57 companies across 387 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Behman's costs compare to other neurologists in Carteret?
Dr. Behman's average Medicare payment per service is $95. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Behman) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Neurology
Common procedures, typical costs, and what industry payments mean in neurology.
Same specialty & city
Neurologists in Carteret
Browse neurologists in Carteret ranked by procedure volume and transparency data.
Highest volume
Top Neurologists in NJ
Neurologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Neurologists in NJ
Which NJ neurologists receive the most from drug and device companies.
By company
Lilly USA, LLC Payments to Doctors
See all physicians who received payments from Lilly USA, LLC.
By company
ABBVIE INC. Payments to Doctors
See all physicians who received payments from ABBVIE INC.
By company
AbbVie Inc. Payments to Doctors
See all physicians who received payments from AbbVie Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology